Source: Annual Congress 2010 - Immune modulation of airways diseases
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cazzola, T. A. Tompkins, M. G. Matera (Rome, Italy; Montreal, Canada). Immunomodulatory impact of a synbiotic in T_H1 and T_H2 models of infection. Eur Respir J 2010; 36: Suppl. 54, 1919

Member's Comments

No comment yet.

Related content which might interest you: Immunomodulatory effects of feeding with bifidobacterium longum on allergen induced lung inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Effects of ulinastatin in treatment of invasive candidiasis Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Probiotics and synbiotics: Effects on chronic asthma in mice Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Effects of probiotic supplementation on procalcitonin level and clinical improvements in patients with pneumonia Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 The effect of anti-inflammatory treatment on bacterial rhino-sinusitis in a murine model Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002 Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003 Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Anti-inflammatory treatment Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017 Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Pleiotropic effects of add-on atorvastatin therapy during the treatment of COPD patients Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Effects of prebiotics and synbiotics on asthma outcomes: a systematic review and meta-analysis Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 H.p. is good for you: protective effects of helicobacter infections in airway disease Source: Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases Year: 2013 Effects of moderate aerobic exercise trainning in acute and late phase of lung infection induced by streptococcus pneumoniae Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Impacts of inhaled corticosteroids on antiviral and antibacterial immunity in the lung Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019